查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026831

穿戴式注射器市場預測至2034年—按類型、應用、技術、最終用戶和地區分類的全球分析

Wearable Injectors Market Forecasts to 2034 - Global Analysis By Type, By Usage Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，全球穿戴式注射器市場預計到 2026 年將達到 126 億美元，並在預測期內以 11.9% 的複合年成長率成長，到 2034 年達到 310 億美元。

穿戴式注射器是一種佩戴在身上的小型醫療設備，能夠實現可控且穩定的藥物輸注。這些裝置透過皮下注射給藥，為慢性病患者提供便利且精準的劑量控制。它們形式多樣，通常整合電子或機械系統，從而能夠制定個人化的治療方案，並實現長期持續或間歇給藥。

根據國際糖尿病聯盟（IDF）的估計，到 2045 年，將有超過 7.8 億人患有糖尿病。

慢性病增多

隨著糖尿病、心血管疾病和自體免疫疾病的日益普遍，人們對便利、精準的給藥方式的需求也日益成長。穿戴式注射器提供了一種解決方案，使患者能夠自行給藥，從而提高劑量穩定性並增強治療依從性。其支持慢性病長期治療的能力，滿足了患者對便利用藥和高效管理這些持續健康挑戰的需求，推動了市場成長。

穿戴式注射器的相關成本

穿戴式注射器的成本因素是限制其市場發展的因素。由於其技術先進、製造流程複雜且需要特殊材料，這些設備通常價格昂貴。高成本可能成為部分患者獲得該設備的障礙，並阻礙其廣泛應用。此外，保險報銷和醫療預算限制等問題也進一步阻礙了其普及。

醫療基礎設施的發展和文明病的增加

隨著醫療保健體系的進步，以病人為中心的照護和創新的給藥方式日益受到關注。穿戴式注射器順應了這一趨勢，為現代生活中常見的慢性病管理提供了一種便捷的自我給藥方式。這種協同效應為穿戴式注射器滿足慢性病患者的需求、提供高效且便利的給藥解決方案創造了契機，加速了其普及化和市場成長。

對替代藥物輸送系統的傾向

儘管患者和醫療專業人員正在考慮多種治療方案，包括口服藥物和傳統注射，但穿戴式注射器的使用率下降正對市場成長構成挑戰。患者偏好、成本考量以及競爭技術的出現等因素正在分散人們對穿戴式注射器的關注。儘管穿戴式注射器具有精準便捷的給藥優勢，但這種趨勢可能會阻礙其廣泛應用，影響市場滲透率並減緩預期的市場擴張。

新冠疫情的影響：

新冠疫情對穿戴式注射器市場產生了重大影響。擇期手術的延遲、患者就診量的減少以及經濟壓力暫時減緩了穿戴式注射器的普及。然而，疫情凸顯了遠端醫療解決方案的必要性，在醫療服務體係受到衝擊的情況下，患者尋求便捷的居家治療方案，這可能會激發人們對穿戴式注射器的長期興趣和創新。

在預測期內，糖尿病細分市場預計將成為最大的細分市場。

糖尿病領域有望成為穿戴式注射器市場的主要驅動力。隨著全球糖尿病盛行率的上升，對高效且便捷的給藥系統的需求日益成長。穿戴式注射器為糖尿病患者提供了一種便捷的胰島素劑量管理方式，確保劑量精準，提高治療順從性。此外，技術進步以及專為糖尿病管理而設計的便利整合系統的開發，進一步鞏固了該領域的市場主導地位。

預計在預測期內，體外注射器細分市場將呈現最高的複合年成長率。

由於其便攜性和柔軟性，非體表注射器市場預計將迎來顯著成長。使用者無需像佩戴在身上那樣，即可方便地攜帶和使用藥物。尤其是在需要間歇給藥或長期治療的情況下，人們對更隱密、更方便的給藥方式的需求日益成長，這推動了對非體表注射器的需求。此外，其與多種藥物的兼容性以及滿足不同患者偏好的能力，也促進了穿戴式注射器市場中這一細分領域的擴張。

市佔率最大的地區：

北美地區預計將引領穿戴式注射器市場的發展，這主要得益於其先進的醫療保健基礎設施、慢性病高發生率以及精通科技的人口。該地區健全的法規環境也為創新醫療技術的應用提供了支援。不斷成長的醫療保健支出以及主要市場參與者的強大影響力進一步鞏固了北美地區的主導地位。

複合年成長率最高的地區：

由於人口成長、慢性病患病率上升以及健康意識增強，亞太地區的穿戴式注射器市場預計將顯著成長。中國、印度和日本等國的有利政府政策、不斷完善的醫療基礎設施以及創新技術的廣泛應用，都促進了市場擴張。此外，該地區可支配收入的增加以及以患者為中心的醫療模式的轉變，也進一步推動了亞太地區穿戴式注射器市場的成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球穿戴式注射器市場：按類型分類

  • 穿戴式
  • 體外型

第6章 全球穿戴式注射器市場：依使用模式分類

  • 一次性的
  • 半拋棄式
  • 可重複使用的

第7章 全球穿戴式注射器市場：依科技分類

  • 微流體系統
  • 電子系統
  • 混合系統
  • 機械系統
    • 氣球儲氣罐
    • 點滴幫浦
    • 振動系統
    • 旋轉機構
    • 彈簧型
  • 其他技術

第8章 全球穿戴式注射器市場：按應用分類

  • 自體免疫疾病
  • 心血管疾病
  • 糖尿病
  • 免疫力缺乏
  • 感染疾病
  • 腫瘤學
  • 其他用途

第9章 全球穿戴式注射器市場：依最終用戶分類

  • 醫院
  • 診所
  • 居家照護
  • 其他最終用戶

第10章 全球穿戴式注射器市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第11章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • Amgen Inc.
  • Becton, Dickinson and Company
  • CeQur SA
  • Debiotech SA
  • E3D Elcam Drug Delivery Devices
  • Enable Injection Devices Ltd.
  • Insulet Corporation
  • Medtronic plc
  • Nemera Development SA
  • ScPharmaceuticals Inc.
  • Sensile Medical AG
  • SFC Fluidics
  • SteadyMed Therapeutics, Inc.
  • Tandem Diabetes Care, Inc.
  • Unilife Corporation
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG
Product Code: SMRC24662

According to Stratistics MRC, the Global Wearable Injectors Market is accounted for $12.6 billion in 2026 and is expected to reach $31.0 billion by 2034 growing at a CAGR of 11.9% during the forecast period. Wearable injectors are compact medical devices worn on the body, facilitating controlled and consistent drug delivery. These devices administer medication subcutaneously, offering convenience and precise dosing for patients with chronic conditions. They come in various forms, often incorporating electronic or mechanical systems, allowing for personalized treatment plans and enabling continuous or intermittent delivery of medications over extended periods.

According to the International Diabetes Federation, over 780 million people are expected to be living with diabetes, by 2045.

Market Dynamics:

Driver:

Increasing incidence of chronic illnesses

With an increasing prevalence of conditions like diabetes, cardiovascular diseases and autoimmune disorders, there's a growing demand for convenient and precise drug delivery methods. Wearable injectors offer a solution by providing patients with a means to self-administer medications, ensuring consistent dosing and improving treatment adherence. Their ability to accommodate long-term therapy for chronic conditions aligns with the need for enhanced patient convenience and efficient management of these ongoing health challenges, propelling their market growth.

Restraint:

Expenses associated with wearable injectors

The cost factor linked to wearable injectors poses a notable restraint in the market. These devices often entail high expenses due to their sophisticated technology, manufacturing intricacies, and specialized materials. This elevated cost can limit accessibility for some patients, impacting widespread adoption. Additionally, reimbursement challenges and healthcare budget constraints further impede their widespread use.

Opportunity:

Rising healthcare infrastructure and lifestyle disorders

As healthcare systems advance, there's increased emphasis on patient-centric care and innovative drug delivery methods. Wearable injectors align with this trend by offering a user-friendly, self-administered approach for managing chronic conditions prevalent in modern lifestyles. This convergence creates an opportunity for wearable injectors to address the needs of individuals with chronic illnesses, providing efficient and convenient drug delivery solutions, thereby fostering their adoption and market growth.

Threat:

Inclination towards alternative drug delivery systems

While patients and healthcare providers explore diverse options like oral medications or traditional injections, the inclination away from wearable injectors challenges market growth. Factors such as patient preferences, cost considerations, and the development of competing technologies divert attention from wearable injector adoption. This trend might hinder the widespread acceptance of wearable injectors, impacting their market penetration and slowing the anticipated market expansion despite their advantages in precise and convenient drug delivery.

Covid-19 Impact:

The COVID-19 pandemic significantly influenced the wearable injectors market. Delayed elective procedures, reduced patient consultations and financial constraints led to a temporary slowdown in wearable injector adoption. However, the pandemic highlighted the need for remote healthcare solutions, potentially fostering long-term interest and innovation in wearable injectors as patients seek convenient, at-home treatment options amid healthcare disruptions.

The diabetes segment is expected to be the largest during the forecast period

The diabetes segment is poised to lead the wearable injectors market. With the escalating prevalence of diabetes worldwide, there's a growing demand for efficient and convenient drug delivery systems. Wearable injectors offer diabetic patients a way to manage insulin delivery conveniently, ensuring precise dosing and enhancing treatment adherence. Moreover, technological advancements and the development of user-friendly, integrated systems tailored for diabetes management further contribute to the dominance of this segment in the market.

The off-body injectors segment is expected to have the highest CAGR during the forecast period

The off-body injectors segment is set for substantial growth due to the device's portability and flexibility, allowing users to carry and administer medications conveniently without the constraints of being attached to the body. The trend towards more discreet and user-friendly drug delivery methods, especially for treatments requiring intermittent dosing or long-term therapies, drives the demand for off-body injectors. Additionally, their compatibility with various medications and their ability to accommodate diverse patient preferences contribute to their expansion within the wearable injectors market.

Region with largest share:

North America is expected to dominate the wearable injectors market due to a combination of advanced healthcare infrastructure, a high prevalence of chronic diseases and a tech-savvy population. The region's robust regulatory environment supports the adoption of innovative medical technologies. Rising healthcare expenditures and a strong presence of key market players further contribute to North America's leadership.

Region with highest CAGR:

Asia Pacific is positioned for significant growth in the wearable injectors market due to the region's expanding population, rising prevalence of chronic diseases and increasing healthcare awareness. Favorable government initiatives, improving healthcare infrastructure and the growing adoption of innovative technologies in countries like China, India, and Japan contribute to market expansion. Additionally, rising disposable incomes and a shift towards more patient-centric healthcare models in the region further propel the growth of wearable injectors in Asia Pacific.

Key players in the market

Some of the key players in wearable injectors market include Amgen Inc., Becton, Dickinson and Company, CeQur SA, Debiotech SA, E3D Elcam Drug Delivery Devices, Enable Injection Devices Ltd., Insulet Corporation, Medtronic plc, Nemera Development SA, ScPharmaceuticals Inc., Sensile Medical AG, SFC Fluidics, SteadyMed Therapeutics, Inc., Tandem Diabetes Care, Inc., Unilife Corporation, West Pharmaceutical Services, Inc. and Ypsomed Holding AG.

Key Developments:

In May 2023, Enable Injections, Inc. collaborated with Viridian Therapeutics, Inc., a U.S.-based biotechnology company.

In January 2023, Tandem Diabetes Care, Inc. announced the acquisition of AMF Medical SA, manufacturer of Sigi Patch Pump.

In June 2022, AbbVie received US FDA approval for SKYRIZI (risankizumab-rzaa) as the first and only specific interleukin-23 (IL-23) inhibitor for the treatment of adults with moderately to severely active Crohn's disease (CD). It can be self-administered by Subcutaneous Injection (SC) with an On-Body Injector (OBI).

Types Covered:

  • On-body
  • Off-body

Usage Types Covered:

  • Disposable
  • Semi-Disposable
  • Reusable

Technologies Covered:

  • Microfluidic Systems
  • Electronic Systems
  • Hybrid Systems
  • Mechanical Systems
  • Other Technologies

Applications Covered:

  • Autoimmune Disease
  • Cardiovascular Disease
  • Diabetes
  • Immunodeficiency
  • Infectious Disease
  • Oncology
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics
  • Home Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Wearable Injectors Market, By Type

  • 5.1 Introduction
  • 5.2 On-body
  • 5.3 Off-body

6 Global Wearable Injectors Market, By Usage Type

  • 6.1 Introduction
  • 6.2 Disposable
  • 6.3 Semi-Disposable
  • 6.4 Reusable

7 Global Wearable Injectors Market, By Technology

  • 7.1 Introduction
  • 7.2 Microfluidic Systems
  • 7.3 Electronic Systems
  • 7.4 Hybrid Systems
  • 7.5 Mechanical Systems
    • 7.5.1 Balloon Reservoir
    • 7.5.2 Infuser Pump
    • 7.5.3 Oscillatory Systems
    • 7.5.4 Rotary Mechanisms
    • 7.5.5 Spring-Based
  • 7.6 Other Technologies

8 Global Wearable Injectors Market, By Application

  • 8.1 Introduction
  • 8.2 Autoimmune Disease
  • 8.3 Cardiovascular Disease
  • 8.4 Diabetes
  • 8.5 Immunodeficiency
  • 8.6 Infectious Disease
  • 8.7 Oncology
  • 8.8 Other Applications

9 Global Wearable Injectors Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Home Care
  • 9.5 Other End Users

10 Global Wearable Injectors Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Amgen Inc.
  • 12.2 Becton, Dickinson and Company
  • 12.3 CeQur SA
  • 12.4 Debiotech SA
  • 12.5 E3D Elcam Drug Delivery Devices
  • 12.6 Enable Injection Devices Ltd.
  • 12.7 Insulet Corporation
  • 12.8 Medtronic plc
  • 12.9 Nemera Development SA
  • 12.10 ScPharmaceuticals Inc.
  • 12.11 Sensile Medical AG
  • 12.12 SFC Fluidics
  • 12.13 SteadyMed Therapeutics, Inc.
  • 12.14 Tandem Diabetes Care, Inc.
  • 12.15 Unilife Corporation
  • 12.16 West Pharmaceutical Services, Inc.
  • 12.17 Ypsomed Holding AG

List of Tables

  • Table 1 Global Wearable Injectors Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Wearable Injectors Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Wearable Injectors Market Outlook, By On-body (2023-2034) ($MN)
  • Table 4 Global Wearable Injectors Market Outlook, By Off-body (2023-2034) ($MN)
  • Table 5 Global Wearable Injectors Market Outlook, By Usage Type (2023-2034) ($MN)
  • Table 6 Global Wearable Injectors Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 7 Global Wearable Injectors Market Outlook, By Semi-Disposable (2023-2034) ($MN)
  • Table 8 Global Wearable Injectors Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 9 Global Wearable Injectors Market Outlook, By Technology (2023-2034) ($MN)
  • Table 10 Global Wearable Injectors Market Outlook, By Microfluidic Systems (2023-2034) ($MN)
  • Table 11 Global Wearable Injectors Market Outlook, By Electronic Systems (2023-2034) ($MN)
  • Table 12 Global Wearable Injectors Market Outlook, By Hybrid Systems (2023-2034) ($MN)
  • Table 13 Global Wearable Injectors Market Outlook, By Mechanical Systems (2023-2034) ($MN)
  • Table 14 Global Wearable Injectors Market Outlook, By Balloon Reservoir (2023-2034) ($MN)
  • Table 15 Global Wearable Injectors Market Outlook, By Infuser Pump (2023-2034) ($MN)
  • Table 16 Global Wearable Injectors Market Outlook, By Oscillatory Systems (2023-2034) ($MN)
  • Table 17 Global Wearable Injectors Market Outlook, By Rotary Mechanisms (2023-2034) ($MN)
  • Table 18 Global Wearable Injectors Market Outlook, By Spring-Based (2023-2034) ($MN)
  • Table 19 Global Wearable Injectors Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 20 Global Wearable Injectors Market Outlook, By Application (2023-2034) ($MN)
  • Table 21 Global Wearable Injectors Market Outlook, By Autoimmune Disease (2023-2034) ($MN)
  • Table 22 Global Wearable Injectors Market Outlook, By Cardiovascular Disease (2023-2034) ($MN)
  • Table 23 Global Wearable Injectors Market Outlook, By Diabetes (2023-2034) ($MN)
  • Table 24 Global Wearable Injectors Market Outlook, By Immunodeficiency (2023-2034) ($MN)
  • Table 25 Global Wearable Injectors Market Outlook, By Infectious Disease (2023-2034) ($MN)
  • Table 26 Global Wearable Injectors Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 27 Global Wearable Injectors Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 28 Global Wearable Injectors Market Outlook, By End User (2023-2034) ($MN)
  • Table 29 Global Wearable Injectors Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 30 Global Wearable Injectors Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 31 Global Wearable Injectors Market Outlook, By Home Care (2023-2034) ($MN)
  • Table 32 Global Wearable Injectors Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.